Cargando…

Mitotic rate and S-phase fraction as prognostic factors in stage I cutaneous malignant melanoma.

Clinical data from 369 patients with clinical stage I cutaneous malignant melanoma treated in Kuopio University Hospital district between 1974 and 1989 with a mean follow-up of 6.4 years were analysed. Clinical parameters, histology, DNA index, S-phase fraction (SPF) and mitotic indices [mitotic act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karjalainen, J. M., Eskelinen, M. J., Nordling, S., Lipponen, P. K., Alhava, E. M., Kosma, V. M.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150319/ https://www.ncbi.nlm.nih.gov/pubmed/9667668

Ejemplares similares

Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration.
por: Setälä, L. P., et al.
Publicado: (1996)

Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 α in cutaneous melanoma
por: Karjalainen, J M, et al.
Publicado: (2000)

p21(WAF1/CIP1)expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival
por: Karjalainen, J M, et al.
Publicado: (1999)

p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis
por: Ropponen, K M, et al.
Publicado: (1999)

Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate
por: Setälä, L P, et al.
Publicado: (1999)

Prognostic factors in gastric carcinoma - reply
por: Setälä, Leena, et al.
Publicado: (1997)

Prognostic significance of regression and mitotic rate in head and neck cutaneous melanoma
por: Kim, Elizabeth, et al.
Publicado: (2020)

Nucleolar organiser regions (AgNORs) as predictors in transitional cell bladder cancer.
por: Lipponen, P. K., et al.
Publicado: (1991)

α-Catenin expression has prognostic value in local and locally advanced prostate cancer
por: Aaltomaa, S, et al.
Publicado: (1999)

Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy.
por: Vesalainen, S., et al.
Publicado: (1994)

Cell proliferation of transitional cell bladder tumours determined by PCNA/cyclin immunostaining and its prognostic value.
por: Lipponen, P. K., et al.
Publicado: (1992)

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
por: Lipponen, P., et al.
Publicado: (1994)

The relationship between mitotic rate and depth of invasion in biopsies of malignant melanoma
por: Ghasemi Basir, Hamid Reza, et al.
Publicado: (2018)

Cutaneous malignant melanoma in Scotland.
por: MacKie, R. M., et al.
Publicado: (1982)

Expression of cyclins A and D and p21((waf1/cip1)) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival
por: Aaltomaa, S, et al.
Publicado: (1999)

Staging of cutaneous melanoma
por: Mohr, P., et al.
Publicado: (2009)

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
por: Atzpodien, J, et al.
Publicado: (2007)

Expression of tumour-suppressor gene Rb, apoptosis-suppressing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma.
por: Lipponen, P., et al.
Publicado: (1995)

Cutaneous malignant melanoma in Northern Ireland.
por: Pedlow, P. J., et al.
Publicado: (1997)

Cutavirus in Cutaneous Malignant Melanoma
por: Mollerup, Sarah, et al.
Publicado: (2017)

Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
por: Sandru, Angela, et al.
Publicado: (2014)

Dermoscopic characteristics of melanoma according to the criteria „ulceration“ and „mitotic rate“ of the AJCC 2009 staging system for melanoma
por: Deinlein, Teresa, et al.
Publicado: (2017)

Challenges in staging and surveillance of patients with neurofibromatosis and cutaneous malignant melanoma
por: Chew, P.R., et al.
Publicado: (2019)

Prognostic impact of p62 expression in cutaneous malignant melanoma
por: Ellis, Robert A, et al.
Publicado: (2013)

Problems with registration of cutaneous malignant melanoma in England.
por: Melia, J., et al.
Publicado: (1995)

The growth pattern and microvasculature of pancreatic tumours induced with cultured carcinoma cells
por: Mäkinen, K, et al.
Publicado: (2000)

Imaging tests in cutaneous malignant melanoma staging: a retrospective cohort()()
por: Souza, Luiza Boava, et al.
Publicado: (2020)

Prognostic significance of LKB1 promoter methylation in cutaneous malignant melanoma
por: Zhang, Weiming, et al.
Publicado: (2017)

MALIGNANT MELANOMA – CUTANEOUS METASTASES
por: Padmavathy, L, et al.
Publicado: (2008)

Cutaneous Horn Malignant Melanoma
por: Nishida, Haruto, et al.
Publicado: (2013)

Sunburn, suntan and the risk of cutaneous malignant melanoma--The Western Canada Melanoma Study.
por: Elwood, J. M., et al.
Publicado: (1985)

Genetic determinants of cutaneous malignant melanoma in Sinclair swine.
por: Blangero, J., et al.
Publicado: (1996)

Malignancy Rate of Indeterminate Findings on FDG-PET/CT in Cutaneous Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

Clinical Characteristics of Cutaneous Melanoma and Second Primary Malignancies in a Dutch Hospital-Based Cohort of Cutaneous Melanoma Patients
por: van der Velden, Haike M. J., et al.
Publicado: (2009)

The Influence of Pregnancy on the Recurrence of Cutaneous Malignant Melanoma in Women
por: Albersen, M., et al.
Publicado: (2010)

A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging
por: Brunner, Georg, et al.
Publicado: (2018)

Comparison of Prognostic Factors for Merkel Cell Carcinoma, Mucosal Melanoma and Cutaneous Malignant Melanoma: Insights into Their Etiologies
por: Dennis, Leslie K., et al.
Publicado: (2023)

DNA ploidy and S-phase in primary malignant melanoma as prognostic factors for stage III disease.
por: Karlsson, M., et al.
Publicado: (1993)

Primary cutaneous malignant melanoma of the breast
por: Kim, Seon Kwang, et al.
Publicado: (2012)

Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
por: Doma, V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_38i36lv1pmki8ka34702bnf32i